Latest news with #CROs
Yahoo
25 minutes ago
- Health
- Yahoo
Clinical Trial Monitoring Online Training Course: July 21-22, 2025 - Gain Insights Into How New Monitoring Approaches are Shaping the Future of Clinical Trials
Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring Training Course" training has been added to offering. With regulatory inspectors increasingly finding GCP issues with monitoring clinical trials, it is becoming even more important for the biopharmaceutical industry, study sites, and CROs to employ efficient and accurate strategies for monitoring clinical trials. Also, the global COVID-19 pandemic has changed the ways clinical trials are monitored and resulted in remote and centralized monitoring techniques at the forefront of monitoring. This has created an environment that requires monitors to not only purely focus on site visits. Regulatory authorities promote these alternative ways of monitoring trial data and the future is likely to include a more hybrid monitoring approach. This highly interactive course, which includes group discussions, ensures that monitors not only understand the importance of compliance with the latest GCP standards but also gain insights into how new monitoring approaches are shaping the future of clinical trials. Benefits of Attending Ensure GCP compliance for monitoring clinical trials including during Covid and monitoring approaches for the future Evaluate the development of monitoring plans through protocol analysis for remote risk management Discuss tools and risk evaluation approaches for remote monitoring Ensure appropriate site selection, initiation, monitoring, and close out visits are carried out including during a pandemic Review sponsor and CRO oversight of monitors Certifications CPD: 12 hours for your records Certificate of completion Who Should Attend? Monitors Clinical research associates (CRA) Clinical trial managers Study coordinators Project managers Research nurses Study site assistants Those responsible for oversight of monitoring Investigators seeking to move into clinical trial monitoring This course will benefit those involved in the monitoring of clinical trials, including new and soon-to-be monitors. This will also be an ideal refresher including how monitoring has changed because of the pandemic and those responsible for oversight of monitors. Key Topics Covered Day 1 ICH GCP R3 Compliance considerations for monitoring clinical trials for the future What is the role of the monitor/CRA to comply with GCP and changes as a result of the pandemic and technological advances? The monitoring role in the context of having a quality system for clinical trials ICH E6R3 and update and impact on monitoring Site selection Criteria for selecting suitable sites Site Feasibility Assessment Site initiation Preparing for site initiation Agenda and content of site initiation visit report to comply with GCP Risks of inappropriate site initiation & resulting issues Monitoring visit procedures Preparing for site monitoring Important consideration during SDV and virtual clinical trials Identifying issues and developing solutions Monitoring visit report to comply with GCP Day 2 Study close-out visits Preparing for site closure Final preparing of documentation and entering data Content of closeout visit and follow-up to comply with GCP Planning Patient recruitment strategies Optimising recruitment to clinical trials Common recruitment problems in clinical trials and how these may be managed Oversight of monitoring Co-monitoring visits including by the sponsor and CRO management Preparing a sponsor monitoring oversight visit Follow-up with the monitor/CRO GCP, documentation and archiving Requirements of the GCP Inspectors TMF considerations Reporting serious breaches and preventing fraud: what monitors need to know What are the signs a monitor should look for serious breaches and fraud? What actions should the monitor take? How to report serious breaches Preparing for audit and inspection visits to comply with GCP How to prepare effectively for a study site audit and/or regulatory inspection What do QA departments and inspectors look for? A brief review of regulatory authority inspections findings SpeakerLaura Brown Pharmaceutical QA and Training Consultant, University of Cardiff Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Clinical Trial Management System Market Size to Hit USD 5.93 Billion by 2032, Fueled by AI Integration and Rising Clinical Trial Complexity
According to Research by SNS Insider, U.S. Clinical Trial Management System Market Leads Global Growth; Surge in R&D, Government Initiatives, and Technological Advancements Fuel Market Expansion Austin, June 04, 2025 (GLOBE NEWSWIRE) -- Clinical Trial Management System Market Size & Growth Analysis: According to SNS Insider, The Clinical Trial Management System Market size was estimated at USD 1.80 billion in 2023 and is expected to reach USD 5.93 billion by 2032, at a CAGR of 14.18% during the forecast period of 2024-2032. The clinical trial management system market is growing rapidly, driven by the growing complexity in clinical trials and the increasing requirement for efficient solutions to manage trials. Cloud adoption, artificial intelligence, and real-time data analytics are improving the capabilities of the system and allowing operational efficiency to scale a Sample Report of Clinical Trial Management System Market@ The U.S. clinical trial management system market was estimated at USD 0.78 billion in 2023 and is expected to reach USD 2.55 billion by 2032, at a CAGR of 14.06% during the forecast period of 2024-2032. The U.S. remains the most dominant in North America, owing to the availability of advanced research infrastructure, high frequency of clinical trial activity, and presence of top 10 pharmaceutical and biotech companies. Clinical Trial Management System Market Report Scope Report Attributes Details Market Size in 2023 US$ 1.8 billion Market Size by 2032 US$ 5.93 billion CAGR CAGR of 14.18% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Key Segments By Solution Type (Enterprise, Site)By Delivery Mode (Web & Cloud Based, On Premise)By Component (Software, Services)By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs & Others) Segmentation Insights By Solution Type, Enterprise Segment Dominated the Market The enterprise segment held the largest share of about 73% of the clinical trial management system market in 2023, which can be attributed to the strong capabilities that enterprise CTMS offers to handle complex multi-site clinical trials. Enterprise-level CTMS was preferred by large pharmaceutical companies and contract research organizations (CROs) due to scalability, integrated workflow management, and advanced data analytics. By Component, Software Segment Dominated the Market In 2023, the software segment accounted for 55% of market share in the clinical trial management system market due to the growing demand for digital tools to manage clinical trial planning, tracking & management. CTMS software solutions are tailored for managing the complex logistics of preparing, recruiting patients, maintaining budgets, and navigating regulatory hurdles, all functions that are necessary for executing a trial successfully. By Delivery Mode, Web & Cloud-Based Segment Dominates the Market with 69% Market Share The web & cloud-based segment accounted for the highest market share in 2023, owing to its flexibility, scalability, and cost-efficient nature. These solutions provide real-time access to data from various locations for a clinical trial, allowing better collaboration between clinical teams. Increasing inclination towards decentralized and remote trials further propelled traction for cloud-operated platforms, entailing remote/virtual monitoring and quick integration of data. By End-User, the CRO Segment Dominates the Clinical Trial Management System Market with the Highest Market Share The CRO segment was the highest contributor to the market in 2023, accounting for a 39% market share, owing to the increasing trend of pharmaceutical and biotech companies outsourcing clinical trials to CROs to become more efficient and save costs. Given the need for CROs to run many complex trials at once, meet an ever-growing set of regulatory requirements, provide data quality, and streamline processes, they depend heavily on CTMS platforms. Need Any Customization Research on Clinical Trial Management System Market, Enquire Now@ Major Players Analysis Listed in this Report are: Medidata Solutions Oracle Corporation Veeva Systems Parexel International IBM Watson Health BioClinica eClinicalWorks MedNet Solutions Deloitte Life Sciences & Healthcare MasterControl North America Leads the Clinical Trial Management System Market, Asia-Pacific Set to Witness Fastest Growth In 2023, North America dominated the market with a 51% market share of the clinical trial management system market, driven by the availability of a well-established clinical research infrastructure, a strong presence of biopharmaceutical industries, and a favorable regulatory authority. High investments in R&D, significant active clinical trials, and high adoption of advanced digital tools to manage clinical trial complexity are driving the region. Through the forecast period, the CTMS market in Asia-Pacific will grow at the fastest rate, mainly due to the rapid growth of clinical trials in countries such as China, India, and South Korea. This has opened a market for global biotech and pharmaceutical companies looking to expand their strong regulatory environments and benefit from a growing patient pool in the region while also lowering trial costs. Buy a Single-User PDF of Clinical Trial Management System Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Clinical Trial Management System Market by Solution Type 8. Clinical Trial Management System Market by Delivery Mode 9. Clinical Trial Management System Market by Component 10. Clinical Trial Management System Market by End-user 11. Regional Analysis 12. Company Profiles 13. Use Cases and Best Practices 14. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Yahoo
3 days ago
- Business
- Yahoo
United States Clinical Trial Investigative Site Network Market Competition, Forecast & Opportunities to 2030: Rising Adoption of Decentralized and Hybrid Clinical Trials
The U.S. Clinical Trial Investigative Site Network Market is driven by complex trials, rising chronic disease incidence, and partnerships with site networks enhancing efficiency. Key opportunities lie in decentralized and hybrid trial models, supported by digital tools, with ongoing demand for innovation in patient recruitment and retention. U.S. Clinical Trial Investigative Site Network Market Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "United States Clinical Trial Investigative Site Network Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. The United States Clinical Trial Investigative Site Network Market was valued at USD 2.88 Billion in 2024 and is expected to reach USD 4.51 Billion by 2030, rising at a CAGR of 7.73%. The market is expanding steadily, driven by the growing complexity of clinical trials and the increasing need for specialized infrastructure. Rising incidences of chronic illnesses such as cancer, cardiovascular, and neurological diseases are pushing pharmaceutical and biotech firms to speed up drug development through partnerships with site networks. These networks enhance efficiency through centralized coordination, experienced investigators, and improved patient recruitment. The market is also being shaped by the growing adoption of decentralized and hybrid trial models, supported by digital health tools and remote monitoring technologies. Artificial intelligence and machine learning are being utilized to optimize site selection, enrollment forecasts, and protocol design. With the growing emphasis on precision medicine, investigative networks are adjusting recruitment and operational models to support personalized trial approaches. Key Market Drivers: Rising Number of Clinical Trials and Drug Development Activities An increase in clinical trials and drug development activities is a primary growth driver for the United States Clinical Trial Investigative Site Network Market. Growing investments by pharmaceutical and biotechnology firms in innovative therapies have intensified the demand for clinical trials. As of 2024, the U.S. accounted for over 35% of all global clinical trials, underscoring its leadership in the research landscape. The surge in trials for biologics, gene therapies, immunotherapies, and precision medicine by sponsors such as pharma companies, CROs, and academic institutions has amplified the reliance on investigative site networks. Furthermore, expedited approval pathways for breakthrough drugs have encouraged trial expansion across multiple U.S. regions, reinforcing the role of site networks in accelerating therapeutic development. Key Market Challenges: Patient Recruitment and Retention Difficulties Recruiting and retaining patients remains a persistent hurdle in the United States Clinical Trial Investigative Site Network Market. Recruitment is hampered by limited public awareness, complex eligibility requirements, and safety concerns associated with experimental treatments. Specialized trials, particularly in oncology, rare diseases, and CNS disorders, face difficulties in identifying suitable participants, often delaying study timelines and increasing costs. Retention presents another issue, as patients may discontinue participation due to side effects, time constraints, travel demands, or lack of perceived benefits. These barriers are particularly pronounced for individuals in rural or underserved locations. To mitigate these challenges, site networks are incorporating digital tools like telemedicine, mobile health apps, and wearable technology to simplify participation and maintain engagement. While these tools offer promise, patient enrollment and retention continue to pose significant obstacles, necessitating ongoing innovation to support market growth. Key Market Trends: Rising Adoption of Decentralized and Hybrid Clinical Trials The shift toward decentralized and hybrid clinical trial models is a defining trend in the United States Clinical Trial Investigative Site Network Market. Traditional models often require frequent site visits, which can be burdensome for patients, especially those in remote locations. Decentralized trials leverage telehealth, wearable technology, and mobile applications to allow participants to engage remotely, minimizing the need for in-person visits. Hybrid trials combine on-site and virtual components to offer greater flexibility and accessibility. These models are particularly useful in global or geographically diverse studies. Investigative site networks are increasingly integrating technologies that support decentralized approaches, such as real-time monitoring tools, digital biomarkers, and patient engagement platforms. These innovations improve compliance, streamline data collection, and boost patient retention, offering a more adaptive and efficient framework for clinical research. Key Market Players: PAREXEL International ICON plc IQVIA Holdings Inc. Velocity Clinical Research Inc. Elligo Health Research, Inc. WCG Clinical, Inc. Access Clinical Trials Inc. FOMAT Medical Research, Inc. Charles River Laboratories International, Inc. ePharmaSolutions, Inc. Key Attributes: Report Attribute Details No. of Pages 84 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $2.88 Billion Forecasted Market Value (USD) by 2030 $4.51 Billion Compound Annual Growth Rate 7.7% Regions Covered United States Report Scope: In this report, the United States Clinical Trial Investigative Site Network Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: United States Clinical Trial Investigative Site Network Market, By Phase: Phase I Phase II Phase III Phase IV United States Clinical Trial Investigative Site Network Market, By Therapeutic Area: Oncology Cardiology CNS Conditions Pain Management Endocrine Others United States Clinical Trial Investigative Site Network Market, By End User: Pharmaceutical & Biopharmaceutical Companies Medical Device Companies Others United States Clinical Trial Investigative Site Network Market, By Region: North-East Mid-West West South For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Clinical Trial Investigative Site Network Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
20-05-2025
- Business
- Yahoo
TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the 'Outstanding Patient Recruitment and Retention' Category
TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce Health Cloud for industry-leading patient data and IP security CRO Awards SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- TrialWire today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Outstanding Patient Recruitment and Retention category. TrialWire is the AI and algorithm-powered patient-recruitment and enrollment platform, purpose-built on Salesforce Health Cloud to guarantee best-in-class data and IP security. The Platform is a risk share pay-per-enrolled patient offering that accelerates global studies across multiple languages and cultures as well as single country or regional studies, and hybrid decentralized trials. The Platform is specifically designed to rescue stalled trials with its lead product RapidRescue™. Pre-register your study here just in-case Sponsors and CROs who want recruitment certainty from startup can also leverage TrialWire's curated custom patient registry solution GeoClinical™ to boost enrollment from Site activation. TrialWire starts recruiting in under 24 hours and delivers, with complete HIPAA and GDPR compliance, across even the toughest therapeutic areas and protocols. More than 17,000 studies are now pre-registered on the Platform just in case they need a rapid patient recruitment boost. The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards honor CROs that have demonstrated outstanding performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes. 'We are honored to be selected as one of only three global finalists in the Fierce Biotech CRO Awards for 'Outstanding Patient Recruitment and Retention',' said Director Susan Fitzpatrick-Napier. 'We are a young technology company designed to help Sponsors and Sites securely recruit and enroll smarter and faster, and to accelerate communications between Sites and patients to maximize retention. With more than 80% of trials delayed, and often fail, due to patient recruitment issues we are proud to be the go-to solution for some of the most challenging trials, especially in oncology, rare diseases, and CNS. Our recruitment team brings 10+ years of hands-on experience across hundreds of protocols and TAs, while our industry-leading Platform developers have uniquely optimized the experience for patients, Sites, Sponsors, and CROs - meeting the highest standards of data security. Thank you to our clients, partners, and the Fierce Biotech judges for this recognition.' The Fierce CRO Awards finalists were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability and Ethical and Regulatory Adherence. Fierce CRO Awards winners will be announced on June 18. About is the leading digital patient recruitment Platform, purpose-built to address the biopharma challenges of clinical trial enrollment. TrialWire's RapidRescue™ solution combines advanced AI-driven technology, health algorithms, real-time communication tools, and robust data insights. TrialWire rapidly identifies, screens, and connects eligible participants to clinical trials, significantly reducing enrollment timelines and associated costs. The platform is built on Salesforce Health Cloud, ensuring the highest levels of security and compliance. More than 17,000 studies are now pre-registered just in case they need a rapid patient recruitment boost. Pre-register your study here just in-case About Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here. Media ContactDavid JamesMedia Advisor DMG AgencyTeam@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
Europe Contract Research Organization Market Size and Forecast Report 2025-2031: Stiff Competition and Pricing Pressures Hampering Growth
The Europe Contract Research Organization (CRO) Market, valued at $22.88 billion in 2024, is projected to reach $40.02 billion by 2031, growing at a CAGR of 8.3% from 2025 to 2031. Key growth drivers include increased R&D outsourcing and clinical trial demand. Sustainability trends, driven by ESG principles, are reshaping the industry. However, market growth faces challenges due to intense competition and pricing pressures. Key segments include clinical research services and biosimilars, with a major focus on oncology applications. European Contract Research Organization Market Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Europe Contract Research Organization Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product type, Type, Application, and End User" has been added to offering. The Europe Contract Research Organization (CRO) market is anticipated to expand significantly, with projections indicating it will reach US$ 40.02 billion by 2031 from US$ 22.88 billion in 2024, growing at a CAGR of 8.3% from 2025 to 2031. This growth is driven by the escalating outsourcing of research and development and an increased demand for clinical trials. Stakeholders can utilize this forecast to strategically plan their market approach and optimize growth opportunities. A notable trend reshaping the market is the focus on sustainability, influenced by both regulatory demands and societal expectations. CROs are increasingly embedding Environmental, Social, and Governance (ESG) principles into their operations. Companies like TFS HealthScience are at the forefront, aligning with United Nations Sustainable Development Goals (UN SDGs), thus enhancing their reputation and cementing their role in advancing sustainable innovation within the pharmaceutical sector. Despite the positive outlook, the market faces significant constraints due to intense competition. The saturation of the market leads to aggressive pricing strategies as firms vie for clients, putting downward pressure on margins. This pricing dynamic often hampers smaller CROs that lack the economies of scale of larger firms, limiting their capacity for investment in innovation and technology. The commoditization of services further exacerbates this issue, as clients prioritize cost over unique service offerings, driving a "race to the bottom" in pricing. Furthermore, price-conscious clients in the pharmaceutical and biotech sectors leverage competition to negotiate even lower rates, challenging CROs to maintain operational efficiency and service quality. The dual pressures on pricing and margin sustainability stand as significant barriers to market growth. Key industry players referenced in the market analysis include Smerud Medical Research Group, AURIGON GMBH, Pharmaxi LLC, Clinicalark sp. z o.o, Siron Clinical, Julius Clinical, O4 Research Ltd, Medpace Holdings Inc, ProPharma Group, Precision Medicine Group, LLC, Thermo Fisher Scientific (PPD Inc), and Parexel International Corp. Reasons to Buy: Identify market growth opportunities and key players in the European CRO market. Refocus business strategies based on key industry priorities and trends. Develop effective long-term plans leveraging emerging and established market strengths. Analyze regional market dynamics, including driving and restraining factors. Enhance decision-making processes concerning client product strategies, segmentation, pricing, and distribution. Key Attributes: Report Attribute Details No. of Pages 131 Forecast Period 2024 - 2031 Estimated Market Value (USD) in 2024 $22.88 Billion Forecasted Market Value (USD) by 2031 $40.02 billion Compound Annual Growth Rate 8.3% Regions Covered Europe Key Topics Covered: 1. Introduction 2. Executive Summary 3. Research Methodology 4. Europe Contract Research Organization (CRO) Market Landscape 5. Europe Contract Research Organization (CRO) Market - Key Market Dynamics 6. Europe Contract Research Organization (CRO) Market Analysis 7. Europe Contract Research Organization (CRO) Market Analysis - by Service Type 8. Europe Contract Research Organization (CRO) Market Analysis - by Product Type 9. Europe Contract Research Organization (CRO) Market Analysis - by Type 10. Europe Contract Research Organization (CRO) Market Analysis - by Application 11. Europe Contract Research Organization (CRO) Market Analysis - by End User 12. Europe Contract Research Organization (CRO) Market - Country Analysis 13. Industry Landscape 14. Company Profiles Smerud Medical Research Group AURIGON GMBH, Pharmaxi LLC, Clinmark sp. z o.o, Siron Clinical, Julius Clinical, O4 Research Ltd, Medpace Holdings Inc, ProPharma Group, Precision Medicine Group, LLC, Thermo Fisher Scientific (PPD Inc), Parexel International Corp. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment European Contract Research Organization Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
